Skip to main content
Clinical Trials/JPRN-UMIN000012793
JPRN-UMIN000012793
Completed
N/A

Studies on the predictive factors of treatment outcome after intravitreal injection of Lucentis (ranibizumab) in eyes with macular edema associated with central retinal vein occlusion (CRVO) - Effect of ranibizumab in eyes with macular edema associated with CRVO

Ophthalmology, Mie University Hospital0 sites30 target enrollmentJanuary 10, 2014

Overview

Phase
N/A
Intervention
Not specified
Conditions
Central retinal vein occlusion
Sponsor
Ophthalmology, Mie University Hospital
Enrollment
30
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 10, 2014
End Date
January 31, 2016
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Ophthalmology, Mie University Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Any history of previous treatments for CRVO

Outcomes

Primary Outcomes

Not specified

Similar Trials